Use of a combination of variables along with the PCA3 assay in better defining the “low risk” patient : a message from Pretoria to Kyoto

Adam, Ahmed

dc.contributor.author	Adam, Ahmed
dc.date.accessioned	2011-11-15T07:39:53Z
dc.date.available	2012-10-31T00:20:03Z
dc.date.issued	2011-10
dc.description.abstract	The PCA 3 assay has recently been shown to be of benefit in guiding initial prostate biopsy decisions, and has also been externally validated into risk nomograms which can be used to assist clinicians with risk stratification when a decision to biopsy is being contemplated. In view of the above, I am firstly writing to commend Ochiai et al. for a concise review on the first study which assessed the PCA3 assay in a Japanese setting. Their report has been received with great interest in our region.	en_US
dc.description.uri	http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1442-2042	en_US
dc.identifier.citation	Adam, A 2011, 'Use of a combination of variables along with the PCA3 assay in better defining the “low risk” patient : a message from Pretoria to Kyoto', International Journal of Urology, vol. 18, no.10, pp. 736.	en_US
dc.identifier.issn	0919-8172 (print)
dc.identifier.issn	1442-2042 (online)
dc.identifier.other	10.1111/j.1442-2042.2011.02827.x
dc.identifier.uri	http://hdl.handle.net/2263/17580
dc.language.iso	en	en_US
dc.publisher	Wiley-Blackwell	en_US
dc.rights	© 2011 The Japanese Urological Association and Wiley-Blackwell. The definite version is available at http://onlinelibrary.wiley.com. This article is embargoed by the publisher until October 2012.	en_US
dc.subject	Combination	en_US
dc.subject	Variables	en_US
dc.subject	PCA3 assay	en_US
dc.subject	‘Low risk’ patient	en_US
dc.subject	Defining	en_US
dc.subject.lcsh	Prostate -- Cancer -- Diagnosis -- South Africa	en
dc.title	Use of a combination of variables along with the PCA3 assay in better defining the “low risk” patient : a message from Pretoria to Kyoto	en_US
dc.type	Postprint Article	en_US